Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 11%
Buy 56%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is expected to experience continued growth and profitability due to its strong performance and recent acquisitions, making it a promising investment opportunity. Its focus on compliance and reputation protection through its strong corporate culture mitigates potential risks, and its strategic position and cost-saving initiatives in the home-based care market provide a competitive advantage. However, potential risks such as government reimbursement, nurse availability, and regulatory issues should be monitored.

Bears say

Aveanna Healthcare Hldgs is facing several sustainability issues, including its diverse workforce and potential compliance issues. Additionally, the home health industry has a history of fraud, waste, and abuse, which could negatively impact the company's operations. While Aveanna's preferred payor strategy and growing concentration of preferred payer relationships in its Private Duty Services segment are notable differentiators, concern over Medicaid budget pressures is causing share weakness and making investors doubt the company's ability to hit near-term expectations. With a focus on generating free cash flow and reducing debt, Aveanna is also targeting expansion through accretive M&A and leveraging its market density and scale. However, only 20% of the company's directors and 22% of its corporate officers are female or diverse, suggesting a need for greater diversity and inclusion in leadership roles.

AVAH has been analyzed by 9 analysts, with a consensus rating of Buy. 11% of analysts recommend a Strong Buy, 56% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 9 analysts, AVAH has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.